Evidence map›Paper›PMID 25922838›Full record

Trial reportBioMed research international2015

Estradiol Valerate Pretreatment in Short Protocol GnRH-Agonist Cycles versus Combined Pretreatment with Oral Contraceptive Pills in Long Protocol GnRH-Agonist Cycles: A Randomised Controlled Trial.

Krzysztof Lukaszuk, Joanna Liss, Michal Kunicki, Waldemar Kuczynski, Ewa Pastuszek, Grzegorz Jakiel, Lukasz Plociennik, Krzysztof Zielinski, Judyta Zabielska

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Ovarian stimulation modalities in poor respondersTurkish journal of medical sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Krzysztof LukaszukINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland ; Department of Nursing, Medical University, 80-952 Gdansk, Poland ; INVICTA Fertility and Reproductive Centre, 00-019 Warsaw, Poland.ORCID 0000-0001-5996-6991
Joanna LissINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland.ORCID 0000-0002-9199-5212
Michal KunickiINVICTA Fertility and Reproductive Centre, 00-019 Warsaw, Poland.
Waldemar KuczynskiCentre for Reproductive Medicine KRIOBANK, 15-879 Białystok, Poland ; Department of Gynecology and Oncological Gynecology, Medical University, 15-276 Białystok, Poland.
Ewa PastuszekINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland ; Department of Nursing, Medical University, 80-952 Gdansk, Poland.
Grzegorz JakielINVICTA Fertility and Reproductive Centre, 00-019 Warsaw, Poland ; Department of Obstetrics and Gynaecology, Medical Centre of Postgraduate Education, 01-813 Warsaw, Poland.
Lukasz PlociennikINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland.
Krzysztof ZielinskiINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland.
Judyta ZabielskaINVICTA Fertility and Reproductive Centre, 80-172 Gdansk, Poland ; Department of Nursing, Medical University, 80-952 Gdansk, Poland.
Gdańsk Medical University · PLMedical University of Białystok · PLPostgraduate School of Molecular Medicine · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The strategy of in vitro fertilization (IVF) procedures relies on the increasing pregnancy rate and decreasing the risk of premature ovulation and ovarian hyperstimulation syndrome. They are also designed to avoid weekend oocyte retrievals. Combined oral contraceptive (OC) pills are among the medicines used to accomplish these objectives. Alternatively, estradiol can be used instead of OC to obtain similar results. The aim of our study was to compare the differences in pregnancy rates (PRs), implantation rates, and miscarriage rates between a short agonist protocol with estradiol priming and a long protocol with combined OC. Of the 298 women who participated in this study, 134 achieved clinical pregnancies (45.0%). A higher PR (58.4%, n = 80, compared to 40.3%, n = 54) was achieved in the long protocol after OC pretreatment group. The implantation rate was also higher for this group (37.8% versus 28.0%; P = 0.03). The miscarriage rate was 15.0% (n = 12) for the long protocol after OC pretreatment group and 20.4% (n = 11) for the short agonist group (P = 0.81). The short agonist protocol required a 5.7% lower human menopausal gonadotropin (hMG) dosage than the long protocol but surprisingly the number of oocytes retrieved was also smaller.

Indexed as

Fertilization in VitroAbortion, SpontaneousContraceptives, Oral, CombinedEstradiolFemaleHumansMenotropinsOocytesPregnancyPregnancy RateContraceptives, Oral, CombinedEstradiolMenotropins

Identifiers

PMID25922838
PMCPMC4398924
OpenAlexW2056170890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.